HIV Prevention Methods
The Latest
Immediate HIV Treatment Initiation With Integrase Inhibitors Leads to Large Drop in Secondary HIV Transmission Among MSM
Integrase inhibitors are known to be potent first-line therapy options. Recent research suggests their benefits extend to onward HIV prevention as well.
Real Talk at SYNChronicity 2020: Black Women Are Essential to Eliminating HIV
Open conversations between care providers and Black women are vitally important in order to empower women with information about HIV and how to protect their health.
This Week in HIV Research: Where the Rubber Meets the Ring
Sept. 10, 2020: Concomitant use of vaginal rings with condoms; benefits of more frequent HIV screening for young MSM; Black MSM, substance use, and the PrEP continuum; HIV outcomes stratified by anti-LGTBQ policy across U.S. states.
This Week in HIV Research: Hep C, That Other Epidemic Within an Epidemic
Sept. 3, 2020: A hepatitis C microelimination program for people living with HIV; PrEP concentrations and gender-affirming hormones; a collaborative intervention to improve opioid prescribing practices; TDF and fracture risk.
Setbacks for Safe Consumption Site Openings Due to COVID-19 Come at a Dangerous Time for Users
Already dealing with legal pushbacks, harm-reduction advocates for safe drug consumption sites now have COVID-19 to blame for slow progress.
Getting PrEP to Those Who Need It During COVID-19 Has Presented New Challenges
Washington, D.C. area community organizations and clinics have moved a lot of prevention efforts online, but much is missing without in-person contact.
This Week in HIV Research: What We Don’t Know Hurts Them
Aug. 20, 2020: HIV knowledge and stigma among health care workers in the southern U.S.; condomless sex vs. HIV risk among MSM; how drug class choice may affect onward transmission risk; STI screening rates among MSM on PrEP.
With Several Curative Therapies for Hepatitis C on the Market, the Research Pipeline for Prevention Continues
The authors of an influential annual report on hepatitis C research and development talk through what's new and evolving in clinical science.
A Vaginal Ring to Prevent HIV Was Given a Positive Opinion by a European Drug Regulator. Here’s What You Need to Know About It.
Two experts discuss the history of the ring, how it works, and when it may come to the United States.
This Week in HIV Research: Why Aren’t We Listening to Ourselves?
Aug. 13, 2020: HCV testing rates among people newly diagnosed with HIV; HCV treatment referrals ammong coinfected people; HIV mortality rates despite free treatment access; mysterious, plummeting CD4 test results.